Charles Nock
Impact in
- Genetics top 10%
- Glioma Diagnosis and Treatment
-
- Cancer Immunotherapy and Biomarkers
- Pancreatic and Hepatic Oncology Research
- Lung Cancer Research Studies
- Cancer Cells and Metastasis
Papers in
- Oncology 4
- Lung Cancer Research Studies 2
- Pancreatic and Hepatic Oncology Research 1
-
- Hedgehog Signaling Pathway Studies 2
- Epigenetics and DNA Methylation 1
- Co-authors
- Andrew E. Sloan (5 shared papers)Douglas B. Einstein (1 shared paper)Joseph A. Bokar (5 shared papers)Afshin Dowlati (5 shared papers)Smitha Krishnamurthi (5 shared papers)Joseph Gibbons (5 shared papers)Archana Radhakrishnan (1 shared paper)Joanna M. Brell (4 shared papers)
- Journals
- Investigational New Drugs (3 papers)Journal of Clinical Oncology (2 papers)Journal for ImmunoTherapy of Cancer (1 paper)JCO Clinical Cancer Informatics (1 paper)Cancer Chemotherapy and Pharmacology (1 paper)
- Partner nations
- United States
In The Last Decade
Charles Nock
15 papers receiving 374 citations
Peers
Comparison fields: 5 of 67
- Genetics 81
- Oncology 149
- Pulmonary and Respiratory Medicine 121
- Cancer Research 39
- Molecular Biology 115
Countries citing papers authored by Charles Nock
This map shows the geographic impact of Charles Nock's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles Nock with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles Nock more than expected).
Fields of papers citing papers by Charles Nock
This network shows the impact of papers produced by Charles Nock. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles Nock. The network helps show where Charles Nock may publish in the future.
Co-authors
The 25 scholars most cited alongside Charles Nock, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 124 | |
| 2 | 2013 | 61 | |
| 3 | 2015 | 53 | |
| 4 | 2022 | 39 | |
| 5 | 2008 | 18 | |
| 6 | 2009 | 17 | |
| 7 | 2008 | 16 | |
| 8 | 2010 | 11 | |
| 9 | 2020 | 10 | |
| 10 | 2022 | 10 | |
| 11 | 2014 | 10 | |
| 12 | 2012 | 7 | |
| 13 | 2016 | 5 | |
| 14 | 2021 | 1 | |
| 15 | 2018 | 1 |
About Charles Nock
Charles Nock is a scholar working on Oncology, Molecular Biology, Genetics, Pulmonary and Respiratory Medicine and Surgery, having authored 15 papers that have together received 383 indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (3 papers), Lung Cancer Research Studies (2 papers), Lung Cancer Treatments and Mutations (2 papers), Hedgehog Signaling Pathway Studies (2 papers), Radiomics and Machine Learning in Medical Imaging (1 paper), Epilepsy research and treatment (1 paper), Pancreatic and Hepatic Oncology Research (1 paper) and Epigenetics and DNA Methylation (1 paper). The work is most often cited by research in Genetics (81 citations), Oncology (149 citations), Pulmonary and Respiratory Medicine (121 citations), Cancer Research (39 citations) and Molecular Biology (115 citations). Charles Nock has collaborated with scholars based in United States. Frequent co-authors include Andrew E. Sloan, Douglas B. Einstein, Joseph A. Bokar, Afshin Dowlati, Smitha Krishnamurthi, Joseph Gibbons, Archana Radhakrishnan, Joanna M. Brell, Abhishek Ray and Alia Hdeib. Their work appears in journals such as Investigational New Drugs, Journal of Clinical Oncology, Journal for ImmunoTherapy of Cancer, JCO Clinical Cancer Informatics and Cancer Chemotherapy and Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.